rs1800405

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000275.3(OCA2):​c.1113C>T​(p.Gly371Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.014 in 1,613,562 control chromosomes in the GnomAD database, including 479 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.017 ( 72 hom., cov: 32)
Exomes 𝑓: 0.014 ( 407 hom. )

Consequence

OCA2
NM_000275.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.64

Publications

8 publications found
Variant links:
Genes affected
OCA2 (HGNC:8101): (OCA2 melanosomal transmembrane protein) This gene encodes the human homolog of the mouse p (pink-eyed dilution) gene. The encoded protein is believed to be an integral membrane protein involved in small molecule transport, specifically tyrosine, which is a precursor to melanin synthesis. It is involved in mammalian pigmentation, where it may control skin color variation and act as a determinant of brown or blue eye color. Mutations in this gene result in type 2 oculocutaneous albinism. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
OCA2 Gene-Disease associations (from GenCC):
  • oculocutaneous albinism type 2
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 15-27990579-G-A is Benign according to our data. Variant chr15-27990579-G-A is described in ClinVar as Benign. ClinVar VariationId is 193573.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.64 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0809 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OCA2NM_000275.3 linkc.1113C>T p.Gly371Gly synonymous_variant Exon 10 of 24 ENST00000354638.8 NP_000266.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OCA2ENST00000354638.8 linkc.1113C>T p.Gly371Gly synonymous_variant Exon 10 of 24 1 NM_000275.3 ENSP00000346659.3
OCA2ENST00000353809.9 linkc.1045-913C>T intron_variant Intron 9 of 22 1 ENSP00000261276.8

Frequencies

GnomAD3 genomes
AF:
0.0165
AC:
2517
AN:
152126
Hom.:
71
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00357
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0842
Gnomad ASJ
AF:
0.00749
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0228
Gnomad FIN
AF:
0.0136
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0111
Gnomad OTH
AF:
0.0220
GnomAD2 exomes
AF:
0.0243
AC:
6102
AN:
251046
AF XY:
0.0218
show subpopulations
Gnomad AFR exome
AF:
0.00234
Gnomad AMR exome
AF:
0.105
Gnomad ASJ exome
AF:
0.00676
Gnomad EAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.0125
Gnomad NFE exome
AF:
0.0107
Gnomad OTH exome
AF:
0.0204
GnomAD4 exome
AF:
0.0138
AC:
20138
AN:
1461318
Hom.:
407
Cov.:
30
AF XY:
0.0138
AC XY:
10024
AN XY:
726988
show subpopulations
African (AFR)
AF:
0.00218
AC:
73
AN:
33476
American (AMR)
AF:
0.103
AC:
4609
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00742
AC:
194
AN:
26132
East Asian (EAS)
AF:
0.000202
AC:
8
AN:
39700
South Asian (SAS)
AF:
0.0252
AC:
2177
AN:
86250
European-Finnish (FIN)
AF:
0.0125
AC:
665
AN:
53224
Middle Eastern (MID)
AF:
0.0121
AC:
70
AN:
5768
European-Non Finnish (NFE)
AF:
0.0104
AC:
11521
AN:
1111668
Other (OTH)
AF:
0.0136
AC:
821
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1073
2145
3218
4290
5363
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
488
976
1464
1952
2440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0166
AC:
2525
AN:
152244
Hom.:
72
Cov.:
32
AF XY:
0.0181
AC XY:
1349
AN XY:
74440
show subpopulations
African (AFR)
AF:
0.00356
AC:
148
AN:
41538
American (AMR)
AF:
0.0847
AC:
1296
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00749
AC:
26
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.0226
AC:
109
AN:
4826
European-Finnish (FIN)
AF:
0.0136
AC:
144
AN:
10590
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0111
AC:
753
AN:
68024
Other (OTH)
AF:
0.0217
AC:
46
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
123
246
370
493
616
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0102
Hom.:
9
Bravo
AF:
0.0211
Asia WGS
AF:
0.0120
AC:
43
AN:
3478
EpiCase
AF:
0.00987
EpiControl
AF:
0.0108

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Aug 29, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 11, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 27884173, 21541274) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Tyrosinase-positive oculocutaneous albinism Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.45
DANN
Benign
0.27
PhyloP100
-1.6
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800405; hg19: chr15-28235725; COSMIC: COSV62347626; API